vs
Side-by-side financial comparison of EZCORP INC (EZPW) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($761.7M vs $382.0M, roughly 2.0× EZCORP INC). Insulet Corporation runs the higher net margin — 12.0% vs 11.6%, a 0.4% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 19.3%). Insulet Corporation produced more free cash flow last quarter ($89.5M vs $31.7M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (24.9% CAGR vs 15.6%).
EZCORP, Inc. is an American pawn shop operator based in Austin, Texas which provides services across the United States and Latin America. It is a publicly traded company listed on the NASDAQ stock exchange and is the second largest pawn shop operator in the U.S. after Cash America International.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
EZPW vs PODD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $382.0M | $761.7M |
| Net Profit | $44.3M | $91.1M |
| Gross Margin | 58.4% | 69.5% |
| Operating Margin | 15.9% | 16.0% |
| Net Margin | 11.6% | 12.0% |
| Revenue YoY | 19.3% | 33.9% |
| Net Profit YoY | 42.8% | 157.3% |
| EPS (diluted) | $0.55 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $761.7M | ||
| Q4 25 | $382.0M | $783.7M | ||
| Q3 25 | $336.8M | $706.3M | ||
| Q2 25 | $311.0M | $649.1M | ||
| Q1 25 | $306.3M | $569.0M | ||
| Q4 24 | $320.2M | $597.5M | ||
| Q3 24 | $294.6M | $543.9M | ||
| Q2 24 | $281.4M | $488.5M |
| Q1 26 | — | $91.1M | ||
| Q4 25 | $44.3M | $101.6M | ||
| Q3 25 | $26.7M | $87.6M | ||
| Q2 25 | $26.5M | $22.5M | ||
| Q1 25 | $25.4M | $35.4M | ||
| Q4 24 | $31.0M | $100.7M | ||
| Q3 24 | $15.2M | $77.5M | ||
| Q2 24 | $17.9M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | 58.4% | 72.6% | ||
| Q3 25 | 59.0% | 72.2% | ||
| Q2 25 | 59.1% | 69.7% | ||
| Q1 25 | 58.3% | 71.9% | ||
| Q4 24 | 57.9% | 72.1% | ||
| Q3 24 | 59.5% | 69.3% | ||
| Q2 24 | 59.2% | 67.7% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 15.9% | 18.7% | ||
| Q3 25 | 11.0% | 16.7% | ||
| Q2 25 | 11.6% | 18.7% | ||
| Q1 25 | 11.2% | 15.6% | ||
| Q4 24 | 13.1% | 18.3% | ||
| Q3 24 | 8.8% | 16.2% | ||
| Q2 24 | 7.9% | 11.2% |
| Q1 26 | — | 12.0% | ||
| Q4 25 | 11.6% | 13.0% | ||
| Q3 25 | 7.9% | 12.4% | ||
| Q2 25 | 8.5% | 3.5% | ||
| Q1 25 | 8.3% | 6.2% | ||
| Q4 24 | 9.7% | 16.9% | ||
| Q3 24 | 5.2% | 14.2% | ||
| Q2 24 | 6.4% | 38.6% |
| Q1 26 | — | $1.30 | ||
| Q4 25 | $0.55 | $1.42 | ||
| Q3 25 | $0.35 | $1.24 | ||
| Q2 25 | $0.34 | $0.32 | ||
| Q1 25 | $0.33 | $0.50 | ||
| Q4 24 | $0.40 | $1.38 | ||
| Q3 24 | $0.20 | $1.08 | ||
| Q2 24 | $0.25 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $465.9M | $480.4M |
| Total DebtLower is stronger | $518.6M | $18.6M |
| Stockholders' EquityBook value | $1.1B | $1.3B |
| Total Assets | $2.0B | $3.0B |
| Debt / EquityLower = less leverage | 0.48× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $480.4M | ||
| Q4 25 | $465.9M | — | ||
| Q3 25 | $469.5M | — | ||
| Q2 25 | $472.1M | — | ||
| Q1 25 | $505.2M | — | ||
| Q4 24 | $174.5M | — | ||
| Q3 24 | $170.5M | — | ||
| Q2 24 | $218.0M | — |
| Q1 26 | — | $18.6M | ||
| Q4 25 | $518.6M | $930.8M | ||
| Q3 25 | $518.1M | $934.9M | ||
| Q2 25 | $517.6M | $939.0M | ||
| Q1 25 | $620.5M | $1.6B | ||
| Q4 24 | $327.7M | $1.3B | ||
| Q3 24 | $327.3M | $1.4B | ||
| Q2 24 | $361.3M | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $990.1M | $1.5B | ||
| Q1 25 | $851.6M | $1.3B | ||
| Q4 24 | $823.9M | $1.2B | ||
| Q3 24 | $804.6M | $1.1B | ||
| Q2 24 | $801.5M | $998.4M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $2.0B | $3.2B | ||
| Q3 25 | $2.0B | $3.0B | ||
| Q2 25 | $1.9B | $3.5B | ||
| Q1 25 | $1.8B | $3.5B | ||
| Q4 24 | $1.5B | $3.1B | ||
| Q3 24 | $1.5B | $3.0B | ||
| Q2 24 | $1.5B | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | 0.48× | 0.61× | ||
| Q3 25 | 0.51× | 0.68× | ||
| Q2 25 | 0.52× | 0.64× | ||
| Q1 25 | 0.73× | 1.21× | ||
| Q4 24 | 0.40× | 1.07× | ||
| Q3 24 | 0.41× | 1.21× | ||
| Q2 24 | 0.45× | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.1M | $113.8M |
| Free Cash FlowOCF − Capex | $31.7M | $89.5M |
| FCF MarginFCF / Revenue | 8.3% | 11.8% |
| Capex IntensityCapex / Revenue | 2.0% | 3.2% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | $121.7M | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $113.8M | ||
| Q4 25 | $39.1M | $183.3M | ||
| Q3 25 | $51.3M | $125.7M | ||
| Q2 25 | $34.8M | $196.5M | ||
| Q1 25 | $36.9M | $63.8M | ||
| Q4 24 | $26.0M | $147.7M | ||
| Q3 24 | $43.3M | $98.5M | ||
| Q2 24 | $33.7M | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | $31.7M | $48.2M | ||
| Q3 25 | $35.7M | $100.1M | ||
| Q2 25 | $25.7M | $177.9M | ||
| Q1 25 | $28.6M | $51.5M | ||
| Q4 24 | $20.4M | $94.1M | ||
| Q3 24 | $24.4M | $71.8M | ||
| Q2 24 | $30.5M | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | 8.3% | 6.2% | ||
| Q3 25 | 10.6% | 14.2% | ||
| Q2 25 | 8.3% | 27.4% | ||
| Q1 25 | 9.3% | 9.1% | ||
| Q4 24 | 6.4% | 15.7% | ||
| Q3 24 | 8.3% | 13.2% | ||
| Q2 24 | 10.8% | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 2.0% | 17.2% | ||
| Q3 25 | 4.6% | 3.6% | ||
| Q2 25 | 2.9% | 2.9% | ||
| Q1 25 | 2.7% | 2.2% | ||
| Q4 24 | 1.8% | 9.0% | ||
| Q3 24 | 6.4% | 4.9% | ||
| Q2 24 | 1.1% | 4.6% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | 0.88× | 1.80× | ||
| Q3 25 | 1.92× | 1.43× | ||
| Q2 25 | 1.31× | 8.73× | ||
| Q1 25 | 1.45× | 1.80× | ||
| Q4 24 | 0.84× | 1.47× | ||
| Q3 24 | 2.85× | 1.27× | ||
| Q2 24 | 1.88× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EZPW
| Merchandise | $210.1M | 55% |
| Pawn Service | $131.9M | 35% |
| Jewelry Scrap | $39.9M | 10% |
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
